Drugs / S-777469
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00697710 | Jul 2007 → Feb 2008 | atopic eczema | Shionogi | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00703573 | May 2008 → May 2009 | atopic eczema | Shionogi | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-777469 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00703573 ↗ |
| Action | Activate | “CB2 cannabinoid receptor agonist” NCT00697710 ↗1“Cannabinoid CB2 receptor agonist” CHEMBL2019090 ↗ |
| Modality | Small molecule | — CHEMBL2019090 ↗ |
| Target | CNR2 | “Cannabinoid CB2 receptor agonist” CHEMBL2019090 ↗ |